140
Kronik HCV
Philadelphia,1994:820-825.
2.
Marcellin P. Hepatitis C: the clinical spectrum of the disease. Journal of Hepatology,
1999, 31:9-16.
3.
Mast EE, Alter MJ, Margolis HS. Strategies to prevent and control hepatitis B and C
virus infections: a global perspective. Vaccine, 1999, 17:1730-1733.
4 US Department of Health and Human Services.Centers for Disease Control and
Prevention. Recommendations for Prevention and Control of Hepatitis C Virus (HCV)
Infection and HCV-Related Chronic Disease. Morbidity and Mortality Weekly Report,
1998, 47.
5.
World Health Organization. Hepatitis C–global prevalence. Weekly Epidemiological
Record, 1997, 72:341-344.
6 Maheshwari A, Ray S, Thuluvath PJ. Acute hepatitis C. Lancet. 2008;372(9635):321-
32.
7 Chung RT. Acute hepatitis C virus infection. Clin Infect Dis. 2005;41 Suppl 1:S14-7
8 Seeff LB: Natural history of chronic hepatitis C. Hepatology 2002, 36(5 Suppl
1):S35-S46
9 Merle P, Trepo C. Treatment of extrahepatic diseases caused by hepatitis B and
hepatitis C viruses. Tomas CH, Lemon S, Zuckerman AJ (edit) In viral hepatitis.
Blacwell Publishing, Third edition, UK 2005: 780-793.
10 Medina J, Garcia-Buey L, Moreno-Otero R. Hepatitis C virus-related extra-hepatic
disease--aetiopathogenesis and management. Aliment Pharmacol Ther. 2004 Jul
15;20(2):129-41.
11
Poynard T, Cacoub P, Ratziu V, Myers RP, Dezailles MH, et al. Fatigue in patients with
chronic hepatitis C. J Viral Hepat. 2002 ;9(4):295-303.
12 Pawlotsky JM, Roudot-Thoraval F, Simmonds P, Mellor J, Ben Yahia MB,et al.
Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus
serotypes. Ann Intern Med. 1995;122(3):169-73.
13 Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, et al. Cryoglobulinemia
in chronic liver diseases: role of hepatitis C virus and liver damage.
Gastroenterology. 1994;106(5):1291-300. Erratum in: Gastroenterology 1995
Feb;108(2):620.
14 Ferri C, Zignego AL, Pileri SA. Cryoglobulins. J Clin Pathol. 2002;55:4-13.
15 Siagris D, Christofidou M, Tsamandas A, Lekkou A, Thomopoulos K, Labropoulou-
Karatza C. Cryoglobulinemia and progression of fibrosis in chronic HCV infection:
cause or effect? J Infect. 2004;49:236-41.
16 Dammacco F, Gatti P, Sansonno D. Hepatitis C virus infection, mixed
cryoglobulinemia, and non-Hodgkin's lymphoma:an emerging picture. Leuk
Lymphoma. 1998;31:463-76
17 Lenzi M, Frisoni M, Mantovani V, , Ricci P, Muratori L, Francesconi R et al.
Haplotype HLA-B8-DR3 confers susceptibility to hepatitis C virus-related mixed
cryoglobulinemia. Blood. 1998;91:2062-6.
18 Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi PL et al. Interferon alfa-
2a therapy in cryoglobulinemia associated with hepatitis C virus.N Engl J Med.
1994;330:751-6.
19 Poynard T, Leroy V, Cohard M, Thevenot T, Mathurin P, Opolon P, Zarski JP. Meta-
analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of
dose and duration. Hepatology. 1996;24:778-89.
20 Mazzaro C, Zorat F, Caizzi M, Donada C, Di Gennaro GMaso LD, et al.Treatment
with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed
